Related references
Note: Only part of the references are listed.Surveillance After Treatment of Localized Breast Cancer: Time for Reappraisal?
Joseph A. Sparano et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Circulating Tumor Cells in Early Breast Cancer
Laura Thery et al.
JNCI CANCER SPECTRUM (2019)
Change in Topoisomerase 1-Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol
Hope S. Rugo et al.
CLINICAL CANCER RESEARCH (2018)
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
Francois-Clement Bidard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Advances in liquid biopsy approaches for early detection and monitoring of cancer
Anna Babayan et al.
GENOME MEDICINE (2018)
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
Francois-Clement Bidard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and-2) of neoadjuvant chemotherapy combined with bevacizumab
J-Y Pierga et al.
ANNALS OF ONCOLOGY (2017)
Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream® system
Priya Balasubramanian et al.
PLOS ONE (2017)
Androgen receptor expression on circulating tumor cells in metastatic breast cancer
Takeo Fujii et al.
PLOS ONE (2017)
Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy
Sabine Kasimir-Bauer et al.
BREAST CANCER RESEARCH (2016)
Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial
C. Helissey et al.
CANCER LETTERS (2015)
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Devon A. Lawson et al.
NATURE (2015)
Circulating tumor cells in newly diagnosed inflammatory breast cancer
Michal Mego et al.
BREAST CANCER RESEARCH (2015)
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
Jeffrey B. Smerage et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial
Hatem A. Azim et al.
BREAST (2013)
The epigenetics of epithelial-mesenchymal plasticity in cancer
Wai Leong Tam et al.
NATURE MEDICINE (2013)
ApoStream™, a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood
Vishal Gupta et al.
BIOMICROFLUIDICS (2012)
Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy
Michal Mego et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Sabine Kasimir-Bauer et al.
BREAST CANCER RESEARCH (2012)
Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression
Caitlin D. May et al.
BREAST CANCER RESEARCH (2011)
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Mario Giuliano et al.
BREAST CANCER RESEARCH (2011)
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2010)
Cancer sternness and metastasis: Therapeutic consequences and perspectives
Joana Monteiro et al.
EUROPEAN JOURNAL OF CANCER (2010)
Are circulating tumor cells predictive of overall survival?
Klaus Pantel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways
Tamer T. Onder et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer
G. Thomas Budd et al.
CLINICAL CANCER RESEARCH (2006)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Share Paper
